Hemodynamic response to exercise with a new class III antiarrhythmic drug: 1-bromo-3,4,3-dibutylaminopropoxy-3-chlorobenzoyl-2-phenyl indolizine hydrochloride (LB)

J. P. Gagnol, G. Brice, P. J. Schwartz, H. L. Stone

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalFederation Proceedings
Volume44
Issue number3
Publication statusPublished - 1985

ASJC Scopus subject areas

  • Medicine(all)

Cite this